Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 4 (2007), Issue 6 (June)

1. Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer.
   Int J Radiat Oncol Biol Phys, 68(3): 801-8. [Abstract] [Full-text]
2. A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer.
   Int J Radiat Oncol Biol Phys, 68(3): 809-16. [Abstract] [Full-text]
3. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC study.
   Cancer Causes Control, 18(6): 603-12. [Abstract] [Full-text]
4. Her signaling in pancreatic cancer.
   Expert Opin Biol Ther, 7(6): 823-9. [Abstract] [Full-text]
5. Wrapping of skeletonized and divided vessels using the falciform ligament in distal pancreatectomy.
   Am J Surg, 194(1): 94-7. [Abstract] [Full-text]
6. Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells.
   Surgery, 141(6): 804-14. [Abstract] [Full-text]
7. Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study.
   Cancer, 109(12): 2547-56. [Abstract] [Full-text]
8. Abnormal expression, highly efficient detection and novel truncations of midkine in human tumors, cancers and cell lines.
   Cancer Lett, 253(1): 60-7. [Abstract] [Full-text]
9. Leptin induces inflammation-related genes in RINm5F insulinoma cells.
   BMC Mol Biol, 8: 41. [Abstract] [Full-text]
10. Induction of an antitumoral immune response by wild-type adeno-associated virus type 2 in an in vivo model of pancreatic carcinoma.
    Pancreas, 35(1): 63-72. [Abstract] [Full-text]
11. Morphometric microvascular characteristics in the prognosis of pancreatic and ampullary carcinoma.
    Pancreas, 35(1): 47-52. [Abstract] [Full-text]
12. Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from Pancreatic Cancer Registry of Japan Pancreas Society.
    Pancreas, 35(1): 42-6. [Abstract] [Full-text]
13. Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis.
    Pancreas, 35(1): 16-21. [Abstract] [Full-text]
14. Identifying early symptoms of pancreatic cancer.
    Clin J Oncol Nurs, 11(2): 245-8. [Abstract] [Full-text]
15. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study.
    Lancet, 369(9578): 2015-20. [Abstract] [Full-text]
16. The case for routine use of adjuvant therapy in pancreatic cancer.
    J Surg Oncol, 95(7): 597-603. [Abstract] [Full-text]
17. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer.
    J Clin Oncol, 25(18): 2607-15. [Abstract] [Full-text]
18. Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942.
    J Clin Oncol, 25(18): 2567-72. [Abstract] [Full-text]
19. CT angiography for delineation of celiac and superior mesenteric artery variants in patients undergoing hepatobiliary and pancreatic surgery.
    AJR Am J Roentgenol, 189(1): W13-9. [Abstract] [Full-text]
20. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Mol Pharmacol, 72(1): 152-61. [Abstract] [Full-text]
21. Laparoscopic distal pancreatectomy: results on a consecutive series of 58 patients.
    Ann Surg, 246(1): 77-82. [Abstract] [Full-text]
22. Middle pancreatectomy: indications, short- and long-term operative outcomes.
    Ann Surg, 246(1): 69-76. [Abstract] [Full-text]
23. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer.
    Ann Surg, 246(1): 61-8. [Abstract] [Full-text]
24. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Ann Surg, 246(1): 52-60. [Abstract] [Full-text]
25. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results.
    Ann Surg, 246(1): 46-51. [Abstract] [Full-text]
26. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
    Am J Gastroenterol, 102(7): 1377-82. [Abstract] [Full-text]
27. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
    Oncogene, 26(30): 4442-52. [Abstract] [Full-text]
28. A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma.
    Dig Dis Sci, 52(8): 1964-72. [Abstract] [Full-text]
29. Computed tomography of pancreatic implantation with malignant transformation of leiomyomatosis peritonealis disseminata in a man.
    Dig Dis Sci, 52(8): 1954-7. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.